Company Update (NYSE:ABT): Abbott Hosts Conference Call for Fourth-Quarter Earnings

[PR Newswire] – The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott’s Investor Relations website at www.abbottinvestor.com. Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 73,000 people. Read more on this. Abbott Laboratories (ABT) , currently valued at $61.97B, opened at $41.68. Looking at the equity, the company’s one day range is $41.40 to $42.18 and has traded between $39.00 and $51.74 over the past year. ABT shares are currently priced at 19.70x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -3.59x forward p/e ratio. The company pays shareholders $1.04 per share in dividend income per year, for a current yield of 2.32%. According to a consensus of 19 analysts, the earnings estimate of $0.61 per share would be $0.10 worse than the year-ago quarter and a $0.02 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $2.16 would be a $0.12 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $5.31 Billion. If realized, that would be a 0.93% decrease over the year-ago quarter. Recently, Morgan Stanley downgraded ABT from Overweight to Equal-Weight (Jan 4, 2016). Previously, Goldman downgraded ABT from Buy to Neutral. When considering if perhaps the stock is under or overvalued, the average price target is $51.47, which is 23.49% above where the stock opened this morning. See more in (NYSE:ABT) Similar Articles: Market Update: Abbott Laboratories (NYSE:ABT) – Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire Young People to Donate Blood Company Update: Abbott Laboratories (NYSE:ABT) – Abbott Reports Third-Quarter 2015 Results Stock Update (NYSE:ABT): Abbott Reports Second-Quarter 2015 Results